EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING
DEAD

Serial Number

85053858

Owner

AMYLIN PHARMACEUTICALS, INC

Attorney

Edward D Grieff

Filing Date

Jun 3, 2010

Add to watchlist:

No watchlists yet
View on USPTO

EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING Trademark

Serial Number: 85053858

EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING is a trademark filed by AMYLIN PHARMACEUTICALS, INC on June 3, 2010. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AMYLIN PHARMACEUTICALS, INC (179 trademarks)

9373 TOWNE CENTRE DRIVE
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

June 3, 2010

Registration Date

Not Registered

Published for Opposition

March 15, 2011

Goods & Services

Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 12, 2011 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 12, 2011 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 10, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 15, 2011 NPUB
PUBLISHED FOR OPPOSITION
Mar 15, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 4, 2011 PREV
ASSIGNED TO LIE
Feb 1, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 3, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 13, 2010 GNRN
NON-FINAL ACTION E-MAILED
Sep 13, 2010 GNRT
NON-FINAL ACTION WRITTEN
Sep 13, 2010 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2010 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Jun 10, 2010 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2010 NWOS
NEW APPLICATION ENTERED
Jun 7, 2010 NWAP